TreeFrog Therapeutics has developed C-Stem™ : a proprietary technology platform for the mass-production of iPSc-based cell therapies.
C-Stem™ secures cell quality (100% genomic integrity), volumes (x100 cell amplification per week) and dramatically reduces cell therapy costs (by 10 today, by 100 tomorrow).